HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.

Abstract
Previously, we detected a 43-kDa tumor-associated antigen (TAA) using the human monoclonal antibody L92, which recognizes the tetramer peptide KYQI. In the present study, cell lines of cytotoxic T lymphocytes (CTL) specific to the gp43 peptide (DLTMKYQIF) were established from peripheral blood lymphocytes (PBL) of melanoma patients. Patients' PBL (n = 326) of different HLA Class I types were assessed for gp43 CTL activity. CTL specific to gp43 peptide were generated only from HLA-A2 melanoma patients and not normal donors. gp43 CTL recognized gp43 peptide-pulsed autologous BLC and T2 HLA-A2 target cell lines. Furthermore, CTL lines were shown to kill both HLA-A2 autologous and HLA-A2 allogeneic melanoma cell lines, indicating that gp43 peptide can be processed endogenously and presented by melanoma cells as a common TAA. The gp43 CTL lines did not kill normal cells. Specific amino acids of the peptide were shown to be important determinants in stimulation and recognition of CTL. gp43 peptide, recognized by both antibodies and T cells of melanoma patients, is a novel TAA peptide that may play an important role in anti-tumor immunity in human.
AuthorsT Takahashi, R F Irie, D L Morton, D S Hoon
JournalCellular immunology (Cell Immunol) Vol. 178 Issue 2 Pg. 162-71 (Jun 15 1997) ISSN: 0008-8749 [Print] Netherlands
PMID9225007 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Glycoproteins
  • HLA-A2 Antigen
  • Neoplasm Proteins
  • Peptides
  • tumor-associated antigen, gp43
Topics
  • Amino Acid Sequence
  • Antibodies, Neoplasm (immunology)
  • Antigens, Neoplasm (immunology)
  • Cytotoxicity, Immunologic
  • Glycoproteins (immunology)
  • HLA-A2 Antigen (immunology)
  • Humans
  • Immunity, Cellular
  • Immunophenotyping
  • Melanoma (immunology)
  • Neoplasm Proteins (immunology)
  • Peptides (immunology)
  • Skin Neoplasms (immunology)
  • Structure-Activity Relationship
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: